A Novel Catalyst System for the Efficient Syntheses of Chiral Alcohols

Summary of the technology

- Innovative chiral bisoxazolidine ligand enables economical synthesis of chiral alcohols from aldehydes.
- Ideal for pharmaceuticals and intermediates, with high yields and enantioselectivities in various reactions.
- Utilizes low-cost alkyl-zinc reagents and offers ligand recycling, ensuring cost efficiency.

Georgetown University

OVERVIEW

Georgetown University is seeking a partner to commercialize a novel ligand catalyst system. Chiral alcohols represent a fundamental component of many active pharmaceuticals and intermediates. The chiral bisoxazolidine ligand developed at Georgetown is very effective in mediating the syntheses of a variety of chiral alcohols from aldehydes. Reactions performed with this system employ low-cost alkyl zincs, making this catalyst an economical and cost-effective tool for synthesizing chiral alcohol products and intermediates. The successful use of the chiral catalysts in asymmetric bond-forming reactions has been demonstrated.

BACKGROUND

The demand for pure chiral compounds has surged, especially in the pharmaceutical industry, where enantiomerically pure drugs offer fewer side effects and increased potency compared to racemic mixtures. Traditional methods were optimized for racemic materials, relying on limited natural sources or time-consuming racemate resolution. To meet the growing need, efficient chiral catalysts emerged, such as those derived from C2-symmetric ligands like BINOL, BOX, salen, DIOP, DUPHOS, and TADDOL. Notably, cost-effective chiral catalysts from accessible chiral bisoxazolidines derived from amino alcohols and diketones have been developed and successfully applied in asymmetric bond-forming reactions.

Benefit

  • The chiral ligand may be recycled.
  • Provides high yields (>87%) and enantioselectivities (>90%) for a wide range of substrates in various reactions
  • The catalyst system uses inexpensive alkyl-zinc reagents

Market Application

  • Versatile Application: Enables synthesis of chiral alcohols from non-chiral aldehydes, with broad potential in pharmaceuticals and intermediates.
  • Diverse Reaction Scope: Successfully applied in aldehyde alkylation, alkynylation, and nitroaldol (Henry) reactions

Publications

  • US patent No. 7,763,734
  • Bisoxazolidine-Catalyzed Enantioselective Alkynylation of Aldehydes. J. Am. Chem. Soc., 2006, 128 (34), 10996-10997Chiral Amplification based on enantioselective dual-phase distribution of a scalemic bisoxazolidine catalyst. Org. Lett., 2007, 9(16), 2965-8.Bisoxazolidine-catalyzed enantioselective alkynylation of aldehydes.”J. Am. Chem. Soc., 2006, 128(34), 10996-7.

Related Keywords

  • Pharmaceutics
  • Pharmaceutical Products / Drugs
  • Biological Sciences
  • Medicine, Human Health
  • catalysis
  • compound
  • asymmetric
  • ligang recycling

About Georgetown University

Our mission is to advance GU’s innovations through strategic alliances and new venture creation, to facilitate the translation of research breakthroughs into tangible solutions, and to cultivate a dynamic and inclusive environment for entrepreneurship. We advance this mission in support of the GU community and for the benefit of society.

Georgetown University

Never miss an update from Georgetown University

Create your free account to connect with Georgetown University and thousands of other innovative organizations and professionals worldwide

Georgetown University

Send a request for information
to Georgetown University

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support